The ePharma Physician® v9.0 Study Reveals the Physician eLandscape Specific to Twenty-Five Specialties
July 23, 2009, New York, NY –
Mark Bard, president of pharmaceutical and healthcare market research company Manhattan Research, will host a complimentary physician marketing webinar on Tuesday, August 4 at 11am and 3pm EDT. The webinar, ePharma Physician® v9.0: Navigating the Physician Digital Resource Mix, will preview the data and insights available in the company’s recently released ePharma Physician® study and advisory service.
ePharma Physician® differentiates itself from Manhattan Research’s broader physician studies by probing deeper into the digital resource and communication preferences of physicians interacting with pharmaceutical, device, and biotech companies online. This group of “ePharma Physicians” has now reached a significant 87% of the total U.S. physician population, making it necessary for manufacturers, agencies, and medical content providers to understand this market and leverage technology in building successful relationships.
“As digital becomes a core part of the brand planning discussion, marketers and our agency clients are demanding deeper insight into the specific sites physicians are using online – and they want to know what these visitors think of their site as well as the competition,” said Mr. Bard. “In addition to tracking online journals, specialty sites, corporate sites, and product sites by specialty, we combine that research with a review of ‘what if’ scenarios to help our clients better understand what physicians want from the next generation of the clinical web.”
During the August 4th webinar, Mr. Bard will review the following key questions:
* In what ways is the shifting professional resource and communication mix affecting physician interaction with pharmaceutical and device companies?
* How can marketers leverage their specific physician audience’s journal, specialty, product and corporate site mix to dictate more intelligent media plans in 2010?
* Is email a viable communication channel in the manufacturer-physician relationship?
* How are companies using interactive detailing, video conferencing, and portals to evolve siloed sales force strategies to 360° customer service models?
* What are the keys to success when building and managing a pharmaceutical customer service portal? What types of features do physician expect from these sites?
Register for this Webinar Today!
Session 1: Tuesday, August 4, 11:00 – 11:30 AM EDT
Register here: https://www2.gotomeeting.com/register/550629875
Session 2: Tuesday, August 4, 3:00 – 3:30 PM EDT
Register here: https://www2.gotomeeting.com/register/766231642
The webinar is intended for qualified business accounts. For assistance in signing up, please email your time preference to firstname.lastname@example.org or call Maureen Malloy at 212-255-7799.
About ePharma Physician® v9.0
ePharma Physician® v9.0 was conducted via online survey methodology in Q2 2009 among 1,517 online practicing U.S. physicians.
Since 2002, the study has determined the leading online physician destinations based on the number of physician visitors as well as the content satisfaction of those who visit. In-depth analysis of top product and corporate pharmaceutical websites, health portals, online journal sites, specialty-specific sites, newsletters and society sites is available as part of the ePharma Physician® v9.0 advisory service. Additional topics include interactive detailing, tech-enabled sales reps, video conferencing, web 2.0 technologies, email use and interest, and pharmaceutical customer service portals, as well as market data for 300+ leading pharmaceutical product websites including Abilify, Actonel, Actos, Advair, Ambien CR, Amitiza, Androgel, Aricept, Asmanex, Astelin, Avandia, Avastin, Avelox, Avodart, Boniva, Botox, Byetta, Celebrex, Chantix, Cialis, Cipro, Concerta, Coreg CR, Crestor, Cymbalta, Daytrana, Depo-Provera, Detrol LA, Diovan, Effexor XR, Enbrel, Evista, Flomax, Flonase, Flovent HFA, Forteo, Fosamax/Fosamax Plus D, Gardasil, Geodon, Humira, Imitrex, Invega, Januvia, Lamictal, Latisse, Levaquin, Levitra, Lexapro, Lipitor, Loestrin 24 Fe, Lovaza, Lovenox, Lunesta, Lupron, Lyrica, Mirena, Namenda, Nasacort, Nasonex, Nexium (purplepill.com), NuvaRing, Pegasys, Plavix, Prevacid, Pristiq, ProAir HFA, Protonix, Provigil, Pulmicort, Relpax, Remicade, Requip, Risperdal, Rozerem, Seasonale, Seasonique, Seroquel, Singulair, Spiriva, Strattera, Symbicort, Tamiflu, Tekturna, Topamax/Topamax360, TriLipix, Ultram ER, Valtrex, Veramyst, Vesicare, Viagra, Vytorin, Vyvanse, Wellbutrin XL, Xyzal, Yaz, Zetia, Zithromax, Zoloft, Zyprexa, Zyvox. A complete list of available product sites is available at http://www.manhattanresearch.com/files/PRESS/ePharma_Physician_v9.0_Product_Site_Listing.pdf.
ePharma Physician® v9.0 also includes the following specialist segments in the research: Allergy and Immunology, Cardiology (Cardiovascular Surgery and Interventional Cardiology), Dermatology, Emergency Medicine, Endocrinology, Family Medicine/General Practice, Gastroenterology, Infectious Disease or HIV physician, Internal Medicine, Nephrology, Neurology, OB/GYN, Oncology-Hematology & Medical, Ophthalmology, Pediatrics, Psychiatry, Pulmonology, Radiology, Rheumatology, Surgery (General), and Urology.
For additional product and subscription information, please visit www.manhattanresearch.com/products/Strategic_Advisory/ePP